StockWatch
·
HomeLiveWeekly

CG Oncology, Inc.

Ticker: 1991792

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-79.35-24.0331.3086.62Q1 FY2024Q2 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q3 FY2025Q1 FY2026

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q1 FY2024Q2 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q3 FY2025Q1 FY2026
PeriodQ1 FY2026Q3 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q2 FY2024Q1 FY2024
INCOME
Revenue1.08-35.3%1.67+3240.0%0.05+25.0%0.04-63.6%0.11+0.0%0.11-79.2%0.53
Total Income1.08-35.3%1.67+3240.0%0.05+25.0%0.04-63.6%0.11+0.0%0.11-79.2%0.53
EXPENSES
Expenditure67.47+27.8%52.80+24.9%42.26+49.1%28.34+9.2%25.96+0.0%25.96+12.9%23.00
PROFIT
Net Profit-60.20-37.4%-43.81-27.2%-34.45-68.8%-20.41-8.0%-18.90+0.0%-18.90-11.6%-16.93
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.71-24.6%-0.57-26.7%-0.45-50.0%-0.30-7.1%-0.28+0.0%-0.28+22.2%-0.36

Corporate Events

Board MeetingCGON
2026
4Jun

Board Meeting

Results of the 2026 Annual Meeting of Stockholders, includin…

SEC Filing ↗
Board MeetingCGON
2026
20May

Board Meeting

President & COO Ambaw Bellete's separation and President Art…

SEC Filing ↗
Board MeetingCGON
2026
13Apr

Board Meeting

CFO Appointment — Jim DeTore appointed as Chief Financial Of…

SEC Filing ↗